title: Treatment of relapsed or refractory acute leukemia: comparison of two different regimens.
authors.affiliation: CHR Bordeaux, Hôpital Haut-Levêque, Pessac, France.
authors.forename: G
authors.initials: G
authors.lastname: Marit
authors.forename: P
authors.initials: P
authors.lastname: Cony
authors.forename: F
authors.initials: F
authors.lastname: Duclos
authors.forename: M
authors.initials: M
authors.lastname: Puntous
authors.forename: A
authors.initials: A
authors.lastname: Broustet
authors.forename: J
authors.initials: J
authors.lastname: Reiffers
mesh_terms: D000208:Acute Disease; D000328:Adult; D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002648:Child; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000601:surgery; D008942:Mitoxantrone / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*
chemical_list: D000677:Amsacrine; D003561:Cytarabine; D005047:Etoposide; D008942:Mitoxantrone